Savara CFO exercises options, holds 536k shares
Savara Inc Chief Financial Officer David L. Lowrance exercised several stock option grants on March 18, 2026, acquiring a total of 366,747 shares of Common Stock through option exercises at strike prices ranging from $1.11 to $4.45 per share.
Rhea-AI Filing Summary
Savara Inc Chief Financial Officer David L. Lowrance exercised several stock option grants on March 18, 2026, acquiring a total of 366,747 shares of Common Stock through option exercises at strike prices ranging from $1.11 to $4.45 per share. To cover exercise costs and tax obligations, 116,760 shares of Common Stock were withheld by the issuer in transactions coded as F, which are tax-withholding dispositions rather than open‑market sales. Following these transactions, Lowrance directly owned 536,032 shares of Savara common stock. The derivative transactions reflect routine option exercises tied to grants that vest in quarterly installments, as described in the footnotes.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 80,684 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) | 75,000 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) | 130,650 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) | 43,063 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) | 12,500 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) | 24,850 | $0.00 | $0.00 |
| Exercise | Common Stock | 80,684 | $1.51 | $122K |
| Exercise Price or Tax Liability | Common Stock | 24,174 | $5.04 | $122K |
| Exercise | Common Stock | 75,000 | $1.59 | $119K |
| Exercise Price or Tax Liability | Common Stock | 23,661 | $5.04 | $119K |
| Exercise | Common Stock | 130,650 | $1.23 | $161K |
| Exercise Price or Tax Liability | Common Stock | 31,885 | $5.04 | $161K |
| Exercise | Common Stock | 43,063 | $1.11 | $48K |
| Exercise Price or Tax Liability | Common Stock | 9,485 | $5.04 | $48K |
| Exercise | Common Stock | 12,500 | $4.45 | $56K |
| Exercise Price or Tax Liability | Common Stock | 11,037 | $5.04 | $56K |
| Exercise | Common Stock | 24,850 | $3.35 | $83K |
| Exercise Price or Tax Liability | Common Stock | 16,518 | $5.04 | $83K |
Footnotes (6)
- F1. The option vested and became exercisable in sixteen equal installments on each quarterly anniversary of November 1, 2016, subject to the reporting person's continued service with the Issuer.
- F2. The option vested and became exercisable in sixteen equal installments on each quarterly anniversary of December 20, 2019, subject to the reporting person's continued service with the Issuer.
- F3. The option vested and became exercisable in sixteen equal installments on each quarterly anniversary of December 16, 2020, subject to the reporting person's continued service with the Issuer.
- F4. The option vested and became exercisable in sixteen equal installments on each quarterly anniversary of December 14, 2021, subject to the reporting person's continued service with the Issuer.
- F5. The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 14, 2023, subject to the reporting person's continued service with the Issuer.
- F6. The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 12, 2024, subject to the reporting person's continued service with the Issuer.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Savara (SVRA) report for CFO David L. Lowrance?
Were any of the Savara (SVRA) CFO’s Form 4 transactions open-market stock sales?
What stock option grants did Savara (SVRA) CFO exercise in this Form 4?
What do the vesting footnotes in the Savara (SVRA) Form 4 indicate about the CFO’s options?
AI-generated analysis. How Rhea-AI works. Not financial advice.